Cote G J, Nguyen I N, Berget S M, Gagel R F
Department of Medicine, Veterans Administration Medical Center, Houston, Texas.
Mol Endocrinol. 1990 Nov;4(11):1744-9. doi: 10.1210/mend-4-11-1744.
The pre-mRNA encoding calcitonin (CT) and CT gene-related peptide (CGRP) is differentially processed in a tissue-specific fashion to include exon 4 (which encodes CT) or exclude this exon and splice to exon 5 (which encodes CGRP). We have used a CT-specific in vitro RNA-processing system to identify cis-acting sequences required to prevent splicing to exon 5. Deletion mapping demonstrated the presence of an element within the first 45 nucleotides of the CT-specific exon 4 that was required to suppress splicing to the CGRP-specific exon 5. This element was able to function in a completely heterologous system to suppress splicing when the CGRP exon was replaced with a constitutive viral exon. The element was unable to suppress splicing in the absence of a proximal CT-specific 3' splice site. Our results suggest that CT-specific splicing requires assisted recognition of its 3' splice site.
编码降钙素(CT)和降钙素基因相关肽(CGRP)的前体mRNA以组织特异性方式进行差异加工,以包含外显子4(编码CT)或排除该外显子并剪接至外显子5(编码CGRP)。我们使用了一种CT特异性的体外RNA加工系统来鉴定阻止剪接至外显子5所需的顺式作用序列。缺失作图表明,CT特异性外显子4的前45个核苷酸内存在一个元件,该元件是抑制剪接至CGRP特异性外显子5所必需的。当CGRP外显子被组成型病毒外显子取代时,该元件能够在完全异源的系统中发挥作用以抑制剪接。在没有近端CT特异性3'剪接位点的情况下,该元件无法抑制剪接。我们的结果表明,CT特异性剪接需要对其3'剪接位点进行辅助识别。